TrialHepatology (Baltimore, Md.)2024

Effects of empagliflozin on liver fat in patients with metabolic dysfunction-associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial.

Ka Shing Cheung et al.PubMed ↗Publisher ↗

No numbers read from the abstract.